N@N

BFS, ABCO, GHDX Expected To Be Up After Next Earnings Releases

^{Published on 2016-10-31 00:45:16 - WOPRAI}
 

October 31, 2016 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Tuesday, November 1st 2016 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and earnings reports. Saul Centers Inc. (NYSE:BFS), The Advisory Board Company (NASDAQ:ABCO), Genomic Health, Inc. (NASDAQ:GHDX) are all expected to be Up After their earnings are released Tuesday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Up After earnings are released Tuesday:

  Symbol  Company                          # of Reports         Quarter  Release Time
  BFS     Saul Centers Inc.                November Earnings    Q3       After
  ABCO    The Advisory Board Company       November Earnings    Q3       After
  GHDX    Genomic Health, Inc.             November Earnings    Q3       After

Saul Centers Inc. (NYSE:BFS) - Saul Centers Inc. is an equity real estate investment trust. It invests in the real estate markets of the United States. The firm operates and manages community and neighborhood shopping center and office properties. Saul Centers Inc. was founded in June 10, 1993 and is based in Bethesda, Maryland..

The Advisory Board Company (NASDAQ:ABCO) - The Advisory Board Company provides best practices research and insight, performance technology software, consulting and management, and data-and tech-enabled services in the United States and internationally. Its best practices research and insight programs include published studies, executive education, proprietary databases and online services, access to experts, executive briefings, and other services. The company s best practices research and insight programs are focused on understanding industry dynamics, identifying best-demonstrated management practices, critically evaluating widely-followed but ineffective practices, and analyzing emerging trends within the health care and education industries. It also offers cloud-based business intelligence and software applications that allow members to combine insights derived from best practices research with their operational and financial data to identify and assess revenue, cost-saving, or performance improvement opportunities; and consulting and management services that provide on-the-ground support for turnaround and performance improvement initiatives, as well as best practice and day-in-day-out professional management of the hospital or medical group areas. In addition, the company provides data- and tech-enabled services that optimize hospital and health system supply chain, as well as strategic, data-driven student engagement and enrollment management, financial aid optimization, and alumni fundraising solutions to the education industry. It offers its services through discrete programs to hospitals, health systems, independent medical groups, pharmaceutical and biotechnology companies, health care insurers, medical device companies, colleges, universities, and other health care-focused organizations and educational institutions. The Advisory Board Company was founded in 1979 and is headquartered in Washington, District of Columbia..

Genomic Health, Inc. (NASDAQ:GHDX) - Genomic Health, Inc., a healthcare company, provides actionable genomic information to personalize cancer treatment decisions in the United States and internationally. It develops and commercializes genomic-based clinical laboratory services that analyze the underlying biology of cancer, allowing physicians and patients to make individualized treatment decisions. The company offers the Oncotype DX invasive breast cancer test that is used for early stage invasive breast cancer patients to predict the likelihood of breast cancer recurrence and chemotherapy benefit. It also provides the Oncotype DX colon cancer test, which is used to predict the likelihood of colon cancer recurrence in patients with stage II disease, as well as for use in patients with stage III disease treated with oxaliplatin-containing adjuvant therapy. In addition, the company provides the Oncotype DX tests for patients with ductal carcinoma in situ, a pre-invasive form of breast cancer; and the Oncotype DX prostate cancer test, which provides a genomic prostate score to predict disease aggressiveness in men with low risk disease, as well as used to enhance treatment decisions for prostate cancer patients in conjunction with the Gleason score or tumor grading. Its development stage pipeline products include Oncotype SEQ product for use in the monitoring and management of various cancer types; and Oncotype TRACK products for non-invasive tumor monitoring. The company offers its products through a network of distributors. Genomic Health, Inc. was founded in 2000 and is based in Redwood City, California..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net